Methadone for Patients with Malignant Psoas Syndrome: Case Series of Three Patients
- 1 July 2015
- journal article
- case report
- Published by Mary Ann Liebert Inc in Journal of Palliative Medicine
- Vol. 18 (7), 645-652
- https://doi.org/10.1089/jpm.2014.0387
Abstract
Malignant psoas syndrome (MPS) is a relatively rare syndrome that accompanies malignancy; the pain associated with MPS is often difficult to control. Methadone is known to be effective in relieving both nociceptive and neuropathic pain. Herein we describe treatment strategies for three patients with MPS, diagnosed by imaging and clinical findings, who responded to methadone treatment. Patient diagnoses, pain characteristics, and treatment were analyzed retrospectively. Subjects were three patients with MPS who presented to Hyogo Cancer Center with pain. A numeric rating scale (NRS; 0-10) was used to assess patients' pain levels. All three patients were diagnosed with malignancies (prostate, cervical, and urachal) and had impaired gait and thigh extension. All had tumor invasion to the iliopsoas muscle, as determined by imaging, and were diagnosed with MPS. After starting methadone, symptoms improved in all patients and they were able to extend the thigh and walk normally. The NRS scores improved by an average of -7.3 points (95% confidence interval [CI] -4.97, -9.69) on Day 14; and the average time until symptom improvement after starting methadone was 2.3 days (95% CI 1.86, 2.80). Methadone may be considered a treatment choice for MPS patients in whom pain is difficult to control.Keywords
This publication has 15 references indexed in Scilit:
- Methadone Overdose and Cardiac Arrhythmia Potential: Findings From a Review of the Evidence for an American Pain Society and College on Problems of Drug Dependence Clinical Practice GuidelineThe Journal of Pain, 2014
- How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trialEuropean Journal Of Cancer, 2011
- Review of Cancer Pain Management in Patients Receiving Maintenance Methadone TherapyAmerican Journal of Hospice and Palliative Medicine®, 2010
- The Malignant Psoas Syndrome Revisited: Case Report, Mechanisms, and Current Therapeutic OptionsJournal of Palliative Medicine, 2010
- Switching from Methadone to a Different Opioid: What Is the Equianalgesic Dose Ratio?Journal of Palliative Medicine, 2008
- Methadone Use in Cancer Patients with Pain: A ReviewJournal of Palliative Medicine, 2002
- Switching From Morphine to Methadone to Improve Analgesia and Tolerability in Cancer Patients: A Prospective StudyJournal of Clinical Oncology, 2001
- Rapid Switching From Morphine to Methadone in Cancer Patients With Poor Response to MorphineJournal of Clinical Oncology, 1999
- The Link between Identity and Crime for the Heroin Addict in Methadone TreatmentInternational Journal of the Addictions, 1993
- Malignant Psoas Syndrome: Recognition of an Oncologic EntityAustralasian Radiology, 1990